Page 29 - CIRN Annual Report 2017-18

SERIOUS OUTCOMES SURVEILLANCE NETWORK

• JJ LeBlanc, M Elsherif, L Ye et al. Burden of vaccine-preventable pneumococcal disease in hospitalized
adults: A Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) network
study. Vaccine 2017 Jun 22; 35(29):3647-3654.

• HD Gillis, ALS Lang, M ElSherif on behalf of the Serious Outcomes Surveillance (SOS) Network of the
Canadian Immunization Research (CIRN), et al. Assessing the diagnostic accuracy of PCR-based detection
of Streptococcus pneumoniae from nasopharyngeal swabs collected for viral studies in Canadian
adults hospitalised with community-acquired pneumonia: a Serious Outcomes Surveillance (SOS)
Network of the Canadian Immunization Research (CIRN) study. BMJ Open 2017; 7: e015008. doi:10.1136/
bmjopen-2016-015008.

• MK Andrew, V Shinde, L Ye, T Hatchette, F Haguinet, G Dos Santos, JE McElhaney, A Ambrose, G
Boivin, W Bowie, A Chit. The importance of frailty in the assessment of infl uenza vaccine eff ectiveness
against infl uenza-related hospitalization in elderly people. The Journal of Infectious Diseases. 2017 Jul
26;216(4):405-14.

• MK Andrew, V Shinde, T Hatchette, A Ambrose, G Boivin, W Bowie, A Chit, G Dos Santos, M ElSherif, K
Green, F Haguinet. Infl uenza vaccine eff ectiveness against infl uenza-related hospitalization during a season
with mixed outbreaks of four infl uenza viruses: a test-negative case-control study in adults in Canada. BMC
infectious diseases. 2017 Dec;17(1):805.

• C Ng, L Ye, SG Noorduyn, M Hux , E Thommes, R Goeree, A Ambrose, MK Andrew, T Hatchette, G Boivin,
W Bowie. Resource Utilization and Cost of Infl uenza Requiring Hospitalization in Canadian Adults: A Study
from the Serious Outcomes Susrveillance Network of the Canadian Immunization Research Network.
Infl uenza and other respiratory viruses. 2017 Nov 10.doi:10.1111/irv.12521.

• A Lang. Validation of PCR-Based Detection and Serotype Deduction of Streptococcus Pneumoniae from
NP Swabs collected for Viral Studies in Cases of CAP. CCfV/ID Research Day, Halifax, NS. April 11, 2017.

• J Leblanc. Discrimination of Vaccine-Preventable Streptococcus Pneumoniae Serotypes using PCR and
Sequencing. CCfV/ID Research Day, Halifax, NS. April 11, 2017.

• A Oliver. Increasing the Diagnostic Yield of Pneumococcal Community Acquired Pneumonia in Hospitalized
Adults using Combinative Laboratory Testing. CCfV/ID Research Day, Halifax, NS. April 11, 2017.

• J Schembri, H Gillis, M Warhuus, S McNeil, J LeBlanc. Multitarget plasmid controls for conventional and
real-time PCR-Based Serotyping of Streptococcus Pneumoniae. CCfV/ID Research Day, Halifax, NS. April
11, 2017.

• Anil Adisesh. The Incidence of Community Acquired Pneumonia by Occupation. CCfV/ID Research Day,
Halifax, NS. April 11, 2017.

• J Leblanc. Discrimination of Vaccine-Preventable Streptococcus pneumoniae Serotypes using PCR and
Sequencing within the cps loci. AMMI, Toronto, ON. May 2017.

• J Leblanc. Multitarget Plasmid Controls for Conventional and Real-Time PCR Serotyping of Streptococcus
pneumoniae. AMMI, Toronto. May 2017.

27